(21).
In Vivo Treatment with Heterologous Antibodies. Mice were treated with injections of 20 #g i.p. of purified anti-Id or anti-Ig antibodies in saline on days 0 and 3, and were bled on day I0 and weekly thereafter. Id levels were assessed by a hemagglutination inhibition (HAI) assay, described in detail elsewhere (1) . Selected mice from each group were subsequently grafted with H-2K I' (C3H) tail skin.
Assessment of Anti-H-2 Activity. Anti-H-2 antibody activity was assessed by both complement (C)-mediated cytotoxicity assays, as described previously (18) and by flow mierofluorometry (FMF), using the fluorescence-actlvated cell sorter (FAGS). For analysis by the FACS, lymph node cell sns~enslons from C3H (H-2K k) or C3H.OH (H-2K d) were prepared. Aliquots containing 10 cells were washed in Hanks' balanced salt solution containing 0.1% BSA and 0.1% Na azide (staining medium). Cells were pelleted (400 g, 5 rain) and resuspended in 25/~1 of test serum from individual mice. Test sera were ultracentrifuged (100,000 g, 25 min) to remove aggregates before their addition to the cells. The cells were incubated with the test sera for 45 mln at 4°G~ washed twice in staining medium, and resuspended in 25 #1 of a mixture of fluoresceinated ~oat F(ab)'2 anti-mouse IgG2 and F(ab)'2 anti-mouse IgG1 at a final dilution of 1:64 of each antibody, The suspension was incubated for an additional 30 min at 4°G, washed twice, and resuspended in 0.4 ml of staining medium for analysis by FMF (FACS II; B-D FACS Systems, Becton, Dickinson & Co., Sunnyvale, Calif.), as previously described (22) . Fluorescence data were collected on 5 × 104 viable cells, and the results were displayed as a curve in which cell number was plotted on the ordinate and fluorescence intensity (fluorescence units, FU) on the abscissa. FU were arbitrary values selected on the basis of the fluorescence intensity of positively stained cells above background fluorescence as determined by the intersection point of curves from genetically positive (H-2K k) and genetically negative cells for each reagent tested (22) .
l Abbreviations used in this paper: BSA, bovine serum albumin; C, complement; FACS, fluorescenceactivated cell sorter; FMF, flow microfluorometry; FU, fluorescence units; HA, hemagglutination; HAl, hemagglutination inhibition; IEF, isoelectric focusing; PBS, phosphate-buffered saline; SRBC, sheep erythrocytes. (24) . Briefly, 5.5 inch vertical slab gels were prepared using a Plexiglass rear gel-forming plate and front glass plates, treated for polyacrylamide gel adherence by the method of Nicolotti (25) . Whole serum or ascites fluid was focused and Id were detected by the method of Keck et al. (26) . Anti-idiotypic antibodies were radioiodinated (x~I; New England Nuclear, Boston, Mass.) by the chloramine T method (specific activity, 0.5 mCi/mg), and 2 X 107 cpm was overlaid on the gels for 16 h. Autoradiographs were exposed for 10-14 d.
Separation of Ig Subclasses and ld-bearing Molecules by AJfinity Chromatography. Anti-idiotypic
antibodies were coupled to cyanogen bromide-activated Sepharose (Pharmacia Fine Chemicals) at a concentration of 5 mg/2 ml of beads. Goat anti-mouse IgG1 and anti-mouse IgG2 sera, previously dialyzed into 0.1 M Na bicarbonate, 0.075 M NaCI, pH 9.0, were coupled in a similar manner using 1 ml serum/4 ml of beads. 0.5 ml of immune ascites from either alloimmunized or anti-Id-treated mice was passed over either a 5-ml anti-Id column or sequentially over 10 ml of mouse anti-IgG subclass affinity columns. The pass-through (nonadherent fraction) was collected and was designated peak I. The adsorbed material (designated peak II) was eluted from the columns with 4 M guanidine-HCl in PBS, pH 7.0. Eluted antibodies were immediately dialyzed into PBS, pH 7.2, concentrated to the original volume, and stored at -20°C.
Results
Specificity of Anti-Idiotypic Reagents. Anti-idiotypic antibodies were purified from the sera of either individual miniature swine or rabbits immunized with purified monoclonal anti-H-2K k antibodies, as described in Materials and Methods. Because both 3-83P and 11-4.1 monoclonal antibodies were derived from BALB/c mice and were of the IgG~, k subclass, the BALB/c myeloma protein LPC-1 was used to remove anti-isotypic and anti-allotypic antibodies from the immune sera. Table II shows representative results after sequential affinity purification of the anti-Id. Anti-Id antibodies prepared in this manner were found to react strongly with the immunogen, as evidenced by the agglutination of Id-coupled SRBC but did not react significantly above background levels (i.e., 24 on FCS-coupled SRBC) with either LPC-1-coupled or other anti-H-2Kk-coupled SRBC. Furthermore, analysis of these anti-idiotypic antibodies by an HAI assay on a series of anti-H-2 antibodies showed no detectable cross-reactive Id on numerous other monoclonal anti-H-2 antibodies, including several with identical serological specifieities (18), nor on anti-H-2 antibodies produced by alloimmunization of BALB/c mice (16) . More recently, however, shared Id have been detected on a small percentage of alloantibodies using the very sensitive FMF antigen- * All samples were adjusted to concentrations ranging from 0.5 to 1 mg/ml for analysis. :~ The low level agglutination of inappropriate Id-coupled cells was less than control agglutination (FCS-SRBC) and, unlike the specific agglutination, could not be inhibited by the appropriate Id. Treatment with rabbit or pig anti-mouse Ig antibodies did not lead to detectable Id. These findings suggested that the inhibition of hemagglutination by immune sera was due to induced Id (designated Id') (1, 27) and not to an antispecies response. The Id' were also found to be detected only by the homologous anti-Id and were not crossreactive with anti-Id directed against other anti-H-2 hybridoma antibodies, as reported previously (16) . The difference in HAI titers between anti-3-83P-and anti-11-4.1-treated mice was due to sensitivity differences between the indicator cells.
In Vivo Treatment of Mice with Anti-Id
(b) GENETIC CONTROL OF IDIOTYPE INDUCTION. The anti-idiotypic reagents used in this study were raised against monoclonal BALB/c anti-H-2K k antibodies. After treatment with anti-Id, BALB/c mice but not B10 mice produced Id' (data not shown), as assayed by HAI. Thus, the induction of Id' molecules in in vivo treated BALB/c animals might be genetically controlled, for example, by genes linked to constant Ig region genes. We therefore investigated the genetic control of induction of Id', using both backcross analysis and allotype congenic recombinant mice. As seen in Table III , only backcross mice that bore the a allotype genes from the BALB/c parent produced Id' after anti-Id administration. Similarly (Table IV) , analyses of sera produced by allotype congenic recombinant mice inoculated with pig anti-l 1-4.1 indicated that, in general, only a allotype mice could make the Id. In one case We have previously shown (7) by FMF that some of the Id-positive molecules induced in anti-Id-treated mice bind H-2K k antigen specifically (Fig. 2) . However, these same sera, when assayed for reactivity against H-2K k spleen cells by microcytotoxicity analysis, revealed either no lysis or minimal lysis of target cells. Because certain subclasses of mouse Ig fix C poorly and are thus poor cytotoxic antibodies, we examined the subclass distribution of anti-H-2K k antibodies induced in anti-Id-treated mice. By FACS analysis, the majority (>75%) of anti-H-2K k antibodies induced in anti-Id-treated mice were of the IgG1 subclass, with a smaller proportion being IgG2 (Fig. 3) . Serum from one anti-Idtreated mouse (1529) was passed successively over both an anti-IgG2 and an anti-IgGz antibody column, and the bound fractions were eluted. These fractions were then examined for eytotoxicity by C-mediated cytotoxicity (Table V) * Ascites (1:2) from mouse 1529 treated with rabbit anti-3-83P. :1: For the affinity purification column, bound antigen is in parentheses, and Roman numerals I and II represent unbound and bound fractions, respectively, after a sequential purification on the Ig-coupled columns.
cytotoxic anti-H-2K u antibody activity, whereas the IgG1 antibodies recovered were essentially devoid of cytotoxic activity. Thus, the IgG1 anti-H-2K k, which does not fix C, was apparently masking the cytotoxic activity of the smaller popuation of C-fixing IgG2 antibodies by competitive binding to the H-2K k cells. These results demonstrate subclass differences between some of the anti-H-2K kinduced antibodies (IgG1 subclass) and the original monoclonal antibody, 3-83P (IgGz~, k), used to prepare the anti-Id. Other differences between the monoclonal immunogen and the Id' molecules were also detected. First, not all of the Id' molecules induced by anti-Id treatment were antigen binding. Only -20% of mice injected with anti-Id expressed antigen-binding Id' molecules, although 100% of treated mice produced Id'. antigen. Although all anti-H-2K k reactivity detected by FMF cell binding was removed by the absorption, significant amounts of residual nonantigen-binding Id' molecules remained. These results suggested that V region differences may exist between the original monoclonal anti-H-2K k antibody and the Id'. Additional evidence for V region differences was obtained by IEF. Fig. 4 depicts the IEF pattern of sera from two mice, 1529 and 1532, treated with rabbit anti-3-83P. The focused sera were overlaid with pig anti-Id labeled with 125I to avoid the effect of anti-rabbit reactivity in the test sera. The autoradiograph illustrated in Fig. 4 shows that the Id' molecules expressed were of limited heterogeneity. In addition, different animals did not express identical bands nor a set of bands corresponding to the 3-83P protein itself. Serum absorptions with spleen cells were carried out to examine the antigenbinding and nonantigen-binding Id' antibodies. Absorption of sera from mouse 1532 with C3H or C3H.OH spleen cells did not change the IEF patterns. These results support the FACS analysis, which suggested that sera from mouse 1532, although Id +, had no anti-H-2 activity. Mouse 1529, however, had two predominant IgG bands that were removed by H-2K k but not H-2K a spleen cells. When the spectrotype of antibodies eluted from the anti-IgG1 column were examined, several sets of bands were evident. These results suggested that the bands represented the expression of multiple V-region genes because mobility differences could not have been caused by subclass heterogeneity. All of these findings suggest that the differences that exist between 3-83P and Id' are V-region related.
Response of Anti-Id-treated Mice to Alloantigen. Although anti-idiotypic antibodies did
not readily detect shared Id in alloantisera, their injection into naive BALB/c mice had a profound effect on the expressed anti-H-2K k antibody repertoire after skin grafting. As shown above, injection of anti-idiotypic antibodies induced anti-H-2K k antibodies in the absence of H-2K k antigen, but this effect was observed in only ~20% of mice tested. Several of the mice that expressed no detectable anti-H-2K k antibodies by cytotoxicity or FMF were skin grafted with tail skin from C3H (H-2 k) mice.
Fla. 4. IEF of sera from mice treated with rabbit anti-3-83P anti-Id overlaid with t25I-pig anti-3-83P. 12~I-labeled pig anti-3-83P anti-Id was overlaid onto isoelectric focused antibodies from rabbit anti-3-83P-treated BALB/c mice. The pH gradient is shown at the left. In some cases, aliquots of test sera were passed through Sepharose columns bearing either anti-ld or anti-IgGl, as indicated, to fractionate the Id' molecules.
Although no significant alteration in skin graft rejection time was observed (data not presented), treatment with anti-Id before skin grafting had a profound effect on the expressed a n t i -H -2 K k repertoire in these mice. Small aliquots of ascites from normal alloimmunized or anti-Id-treated alloimmunized mice were fractionated on an antiId column. T h e various fractions were then assessed for anti-H-2 activity (Fig. 5 ) by F M F and for idiotypy by the inhibition of anti-H-2 activity using anti-Id. T h e activity of conventional alloantisera could not be inhibited by either anti-11-4.1 or anti-3-83P anti-Id before fractionation (data not shown). In addition, only "~5% of the anti-H-2 activity b o u n d to the anti-Id column, none of which was inhibitable by anti-Id. W h e n the b o u n d antibodies were repassed over the column, only a small percentage rebound, suggesting that the original binding was nonspecific. In contrast, Fig. 5 illustrates that anti-H-2 antibodies from a mouse (1528) treated with anti-Id before grafting were significantly inhibited by anti-3-83P anti-Id. The pass-through fraction (peak I) from the anti-Id column could not be inhibited by anti°Id. However, the eluate (peak II) bound H-2K k specifically to a titer of 1:250 and was significantly inhibited by anti-3-83P anti-Id. In fact, if the mixture of anti-H-2K k antibodies and anti-Id were centrifuged (100,000 g, 25 min) before incubation with the lymph node cells, then the binding was totally inhibited. In this and other animals, the Id + anti-H-2K k antibodies represented between 40 and 65% of the total anti-H-2K k activity, as based on FU values. These findings suggest that anti-Id treatment before immunization with alloantigen exerts a profound effect on the repertoire of anti-H-2K k antibodies expressed in the response.
Discussion
In the present studies, we demonstrated that administration of anti-H-2K k anti-Id to animals in the absence of antigen leads to the induction of Id ÷ molecules, as shown by an HAI assay. Two types of antibodies in sera from anti-Id-treated mice could have inhibited hemagglutination of Id-coated SRBC by anti-Id. First, the inhibitory activity might have been due to the induction of anti-anti-Id antibodies. These molecules, although perhaps present in the sera, probably do not represent a significant portion of the inhibiting molecules for several reasons: (a) a small but significant percentage of Id' reacted with H-2K k antigen, as did the original monoclonal Abl antibody. It seems quite unlikely that anti-anti-Id would fortuitously react with these same determinants; (b) unless the binding site was highly conserved, anti-anti-Id would not be expected to react with anti-Id made in two different species, i.e., pig or rabbit, (c) the protocol used for triggering Id', namely, the injection of one or two small doses of anti-Id in saline, was considered a poor immunogenic regimen; and (d) the induction of Id ÷ molecules was found to be linked to Vn genes. It seems unlikely that the immune response to anti-Id would be linked in this manner. In fact, our previous findings 2 that the Id detected on the original monoclonal immunogen was localized to the H chains and evidence in other systems for the expression of Vnencoded determinants on T and B cells (13) support the alternative hypothesis that the anti-Id in some way triggers cells to produce antibodies (Id') that express combining-site related shared idiotopes similar in nature to those of the original immunogen. This hypothesis is consistent with the cascade of Id-anti-Id reaction referred to as Abl-Ab2-Ab3, etc., as described by Cazenave (28) and by Urbain and co-workers (29) . The mechanism for this triggering phenomenon is currently under investigation. However, the fact that most of the Id' is of the IgG1 subclass suggests a role for T cells in this phenomenon (30) . In addition, preliminary studies indicate that BALB/c athymic nude mice do not make Id' after anti-Id treatment (data not shown).
In previous studies (16) , we demonstrated that these anti-Id detect relatively "private" specificities on the hybridomas that were used as immunogens. However, IEF and antibody specificity data suggested that, although of limited heterogeneity, Bluestone the Id' induced in individual BALB/c mice was not a single clonal species of antibody. First, multiple subclasses, including IgG1, IgG2, and probably other antibody subclasses (on the basis of pI) were induced. In addition, the IgG1 response consisted of at least two clones in one animal (1529), as could be determined by band spacing. After studying a small number of Id' animals using IEF techniques, we found that although a few clones are shared between Id' antibodies induced in individual antiId-treated mice, many differ from other Id' and from the original monoclonal antibody against which the anti-Id was raised. In fact, the fine speciflcities of the anti-H-2 antibodies induced by anti-Id-treated mice were different than the specificities of the monoclonal antibodies. For instance, the anti-H-2K k antibodies induced in BALB.B mice treated with anti-Id cross-reacted with H-2K d antigen. Although the expression of Id is under genetic control, the clones expressed could be the result of somatic diversification of members of a restricted family of anti-H-2 antibodies. Amino acid analysis of Id' monoclonal antibodies is currently under way to address this question.
Finally, we found that within the family of Id' there exists a small percentage of antigen-binding molecules, rarely expressed in an allo-immunization. The ability to detect antigen-binding activity in 20% of mice treated with anti-Id in the absence of antigen, in contrast to results in certain other studies (1), might be due to a larger precursor frequency of alloreactive cells. In addition, by triggering antigen-binding Id'-producing cells before alloimmunization, we were able to manipulate the subsequent response to the H-2K k antigen. In fact, after antigen administration, a significant percentage, as much as 65% of the alloantibodies, are Id positive.
As Jerne's (31) network theory might predict, perturbation of the idiotypic/antiidiotypic network could lead to profound effects on subsequent immune responses. Indeed, such a network might exist before immunization and might help to regulate the immune responses. We demonstrated that immune responses to major histocompatibility antigens (H-2 in the mouse) can be perturbed by treatment with antiidiotypic antibodies directed against monoclonal anti-H-2 antibodies. These results might reflect possible physiologic significance of Id and anti-Id in anti-H-2 responses and might also contribute to the manipulation of transplantation immunity.
Stlmmary
Anti-idiotypic antibodies were prepared against two monoclonal anti-H-2K k antibodies, 11-4.1 and 3-83P. These reagents were used to examine idiotype (Id) expression on anti-H-2K k antibodies induced by the in vivo administration of the anti-idiotypic antibodies and/or I-I-2K k antigen. Treatment of BALB/c mice with anti-Id induced both antigen-binding and nonantigen-binding Id-positive molecules in the absence of antigen. The level of production of anti-Id-induced Id (Id') has been shown to be linked to VH genes using allotype congenic mice and backcross analyses. The idiotopes expressed on the Id' induced in anti-Id-treated mice were closely related or identical to those of the original monoclonal anti-H-2K k antibody. However, the idiotopes were present on immunoglobulins of different subclasses and in some cases were not all expressed on the same molecules, as reflected by differences in their antigen specificities and isoelectric focusing patterns. In vivo administration of anti-Id had a marked influence on the subsequent humoral response to immunization with H-2 antigen.
